FDA Adverse Event Injury Summary report: N

VERCISE GENUS?

MDR report key: 22719213 · Received August 5, 2025

Report

Report Number
3006630150-2025-06173
Event Type
Injury
Date Received
August 5, 2025
Date of Event
January 9, 2025
Report Date
December 4, 2025
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
MHY
UDI-DI
08714729985044
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CORRECTION TO THE INITIAL MDR IN H6. D2B: ADDITIONAL PRO CODE SELECTION THAT APPLIES TO THE INDICATION OF THIS DEVICE - <NHL, PJS>. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS UPN: M365DB2202450 MODEL: DB-2202-45 SERIAL: (B)(6). BATCH: 7123530 UDI: (B)(4). PRODUCT FAMILY: DBS-LINEAR LEADS UPN: M365DB2202450 MODEL: DB-2202-45 SERIAL: (B)(6). BATCH: 7123584 UDI: (B)(4). PRODUCT FAMILY: DBS-EXTENSION UPN: M365DB312855B0 MODEL: DB-3128-55B SERIAL: (B)(6). BATCH: 5001216 UDI: (B)(4).

Additional Manufacturer Narrative · 0

D2B: ADDITIONAL PRO CODE SELECTION THAT APPLIES TO THE INDICATION OF THIS DEVICE - <NHL, PJS>. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2202450, MODEL: DB-2202-45, SERIAL: (B)(6), BATCH: 7123530, UDI: (B)(4). PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2202450, MODEL: DB-2202-45, SERIAL: (B)(6), BATCH: 7123584, UDI: (B)(4). PRODUCT FAMILY: DBS-EXTENSION, UPN: M365DB312855B0, MODEL: DB-3128-55B, SERIAL: (B)(6), BATCH: 5001216, UDI: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THESE DEEP BRAIN STIMULATION (DBS) DEVICES WERE EXPLANTED DUE TO A LOCALIZED INFECTION IN THE HEAD. THE PRIMARY SYMPTOM WAS PUSS DISCHARGE. ALTHOUGH THE EXACT CAUSE OF THE INFECTION REMAINS UNIDENTIFIED, CULTURES REVEALED THE PRESENCE OF BACTERIA BELONGING TO THE SERRATIA GENUS. THE PATIENT WAS SUBSEQUENTLY STARTED ON ANTIBIOTICS. THE PATIENT UNDERWENT AN IMPLANTABLE PULSE GENERATOR (IPG) AND LEADS REVISION PROCEDURE WHEREIN THEIR DEVICES WERE EXPLANTED. THE DEVICES WILL NOT BE RETURNED FOR ANALYSIS. POSTOPERATIVELY, THE PATIENT WAS DOING WELL. AFTER RECOVERING FROM THE EXPLANT PROCEDURE, THE PATIENT RECEIVED A NEW SYSTEM IMPLANT AND IS AWAITING THE PROGRAMMING APPOINTMENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT THESE DEEP BRAIN STIMULATION (DBS) DEVICES WERE EXPLANTED DUE TO A LOCALIZED INFECTION IN THE HEAD. THE PRIMARY SYMPTOM WAS PUSS DISCHARGE. ALTHOUGH THE EXACT CAUSE OF THE INFECTION REMAINS UNIDENTIFIED, CULTURES REVEALED THE PRESENCE OF BACTERIA BELONGING TO THE SERRATIA GENUS. THE PATIENT WAS SUBSEQUENTLY STARTED ON ANTIBIOTICS. THE PATIENT UNDERWENT AN IMPLANTABLE PULSE GENERATOR (IPG) AND LEADS REVISION PROCEDURE WHEREIN THEIR DEVICES WERE EXPLANTED. THE DEVICES WILL NOT BE RETURNED FOR ANALYSIS. POSTOPERATIVELY, THE PATIENT WAS DOING WELL. AFTER RECOVERING FROM THE EXPLANT PROCEDURE, THE PATIENT RECEIVED A NEW SYSTEM IMPLANT AND IS AWAITING THE PROGRAMMING APPOINTMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2497733 VERCISE GENUS? STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY BOSTON SCIENTIFIC NEUROMODULATION CORPORATION DB-1216 596750 08714729985044

Patients

Seq Age Sex Outcome Treatment
1 64 YR Female Required Intervention